IceCure Medical (ICCM) Short-term Investments (2020 - 2025)

IceCure Medical (ICCM) has reported Short-term Investments for 5 consecutive years, with $5.0 million the latest figure, recorded in Q3 2025.

• In Q3 2025, Short-term Investments changed N/A year-over-year to $5.0 million; the TTM figure through Sep 2025 stood at $5.0 million (changed N/A YoY), while the FY2023 annual figure was $529000.0, down 99.82% from the prior year.
• Short-term Investments improved to $5.0 million in Q3 2025 per ICCM's latest filing, from $807000.0 in the prior quarter.
• Across five years, Short-term Investments topped out at $296.0 million in Q4 2022 and bottomed at $295000.0 in Q3 2022.
• Historically, Short-term Investments has averaged $35.7 million across 4 years, with a median of $807000.0 in 2024.
• On a YoY basis, Short-term Investments climbed as much as 220.6% in 2023 and fell as far as 99.82% in 2023.
• IceCure Medical's Short-term Investments stood at $296.0 million in 2022, then sank by 99.82% to $529000.0 in 2023, then soared by 52.55% to $807000.0 in 2024, then surged by 523.79% to $5.0 million in 2025.
• Business Quant data shows ICCM's Short-term Investments at $5.0 million in Q3 2025, $807000.0 in Q2 2024, and $529000.0 in Q4 2023.